Radiomics-based prediction of HCC response to atezolizumab/bevacizumab.

被引：0
|
作者：
Rodriguez, Isaac
Vellala, Abhinay
Itzel, Timo
Vacha, Michael
Chang, De-Hua
Dill, Michael
Seidensticker, Max
Mayerle, Julia
Munker, Stefan
Schoenberg, Stefan O.
Mueller, Lukas
Galle, Peter Robert
Weinmann, Arndt
Tamandl, Dietmar
Pinter, Matthias
Scheiner, Bernhard
Teufel, Andreas
Froelich, Matthias
Ebert, Matthias Philip
Venerito, Marino
机构：
[1] Heidelberg Univ, Med Fac Mannheim, Div Hepatol, Div Hepatol,Div Clin Bioinformat, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Dept Radiol Nucl Med, Mannheim, Germany
[3] Heidelberg Univ, Med Fac Mannheim, Ctr Prevent Med & Digital Hlth Baden Wurttemberg C, Clin Cooperat Unit Hlth Metab, Mannheim, Germany
[4] Cantonal Hosp Lucerne, Dept Radiol, Luzern, Switzerland
[5] Heidelberg Univ Hosp, Dept Gastroenterol Hepatol Infect Dis & Intoxicat, Heidelberg, Germany
[6] Univ Hosp Munich Grosshadern, Munich, Germany
[7] Univ Hosp Munich Grosshadern, Munich, Germany
[8] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 2, Munich, Germany
[9] Univ Med Mannheim, Mannheim, Germany
[10] Univ Med Ctr Mainz, Dept Diagnost & Intervent Radiol, Mainz, Germany
[11] Univ Med Ctr Mainz, I Dept Med, Mainz, Germany
[12] Med Univ Wien, Vienna, Austria
[13] Med Univ Vienna, Hepatol AKH, Vienna, Austria
[14] Med Univ Vienna, Dept Internal Medicine3, Div Gastroenterol & Hepatol, Vienna, Austria
[15] Heidelberg Univ, Mannheim, Germany
[16] Heidelberg Univ, Med Fac Mannheim, Dept Pathol, Mannheim, Germany
[17] Ultratendency Magdeburg, Magdeburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.636
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [1] RADIOMICS-BASED PREDICTION OF HCC RESPONSE TO ATEZOLIZUMAB/BEVACIZUMAB
    Salazar, Isaac Israel Rodriguez
    Teufel, Andreas
    Vellala, Abhinay
    Itzel, Timo
    Daza, Jimmy
    Vacha, Michael
    Debic, Manuel
    Chang, De-Hua
    Dill, Michael
    Seidensticker, Max
    Schonberg, Gerd Oswald Stefan
    Mueller, Lukas
    Mayerle, Julia
    Munker, Stefan
    Galle, Peter
    Weinmann, Arndt
    Tamandl, Dietmar
    Pinter, Matthias
    Venerito, Marino
    Ebert, Matthias
    Froelich, Matthias
    Pech, Maciej
    Sinner, Friedrich
    Scheiner, Bernhard
    HEPATOLOGY, 2024, 80
  • [2] Atezolizumab and bevacizumab. Who is guilty?
    Baselga-Segimon, L.
    Lozano, C. Fernandez
    Rodriguez-Otero, N.
    Elias-Saenz, I.
    Alba-Perez, V.
    Berges-Gimeno, M. P.
    ALLERGY, 2023, 78
  • [3] Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
    Chunli Kong
    Zhongwei Zhao
    Weiyue Chen
    Xiuling Lv
    Gaofeng Shu
    Miaoqing Ye
    Jingjing Song
    Xihui Ying
    Qiaoyou Weng
    Wei Weng
    Shiji Fang
    Minjiang Chen
    Jianfei Tu
    Jiansong Ji
    European Radiology, 2021, 31 : 7500 - 7511
  • [4] Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
    Kong, Chunli
    Zhao, Zhongwei
    Chen, Weiyue
    Lv, Xiuling
    Shu, Gaofeng
    Ye, Miaoqing
    Song, Jingjing
    Ying, Xihui
    Weng, Qiaoyou
    Weng, Wei
    Fang, Shiji
    Chen, Minjiang
    Tu, Jianfei
    Ji, Jiansong
    EUROPEAN RADIOLOGY, 2021, 31 (10) : 7500 - 7511
  • [5] Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
    Bologna, M.
    Calareso, G.
    Resteghini, C.
    Sdao, S.
    Montin, E.
    Corino, V.
    Mainardi, L.
    Licitra, L.
    Bossi, P.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 59 - 59
  • [6] Fusion Radiomics-Based Prediction of Response to Neoadjuvant Chemotherapy for Osteosarcoma
    Zheng, Fei
    Yin, Ping
    Liang, Kewei
    Wang, Yujian
    Hao, Wenhan
    Hao, Qi
    Hong, Nan
    ACADEMIC RADIOLOGY, 2024, 31 (06) : 2444 - 2455
  • [7] Atezolizumab and bevacizumab for HCC in the real world
    Choo, Su Pin
    Nahon, Pierre
    LIVER INTERNATIONAL, 2022, 42 (04) : 727 - 728
  • [8] Thalamus Radiomics-Based Disease Identification and Prediction of Early Treatment Response for Schizophrenia
    Cui, Long-Biao
    Zhang, Ya-Juan
    Lu, Hong-Liang
    Liu, Lin
    Zhang, Hai-Jun
    Fu, Yu-Fei
    Wu, Xu-Sha
    Xu, Yong-Qiang
    Li, Xiao-Sa
    Qiao, Yu-Ting
    Qin, Wei
    Yin, Hong
    Cao, Feng
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [9] ANALYSIS OF ATEZOLIZUMAB ANTIDRUG ANTIBODY IN HCC PATIENTS TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB
    Keishi, Ouchi
    Inoue, Jun
    Ninomiya, Masashi
    Sano, Akitoshi
    Tsuruoka, Mio
    Sato, Kosuke
    Sawahashi, Satoko
    Onuki, Masazumi
    HEPATOLOGY, 2024, 80
  • [10] Radiomics-based Malignancy Prediction of Parotid Gland Tumor
    Kamezawa, H.
    Arimura, H.
    Yasumatsu, R.
    Ninomiya, K.
    Haseai, S.
    INTERNATIONAL FORUM ON MEDICAL IMAGING IN ASIA 2019, 2019, 11050
12345